Anzeige
Mehr »
Login
Freitag, 18.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
5 Millionen Unzen und steigend: NexGold Mining's unerschlossene Goldstraße
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 889250 | ISIN: GB0005774855 | Ticker-Symbol: 14F
Frankfurt
17.10.24
08:18 Uhr
6,200 Euro
+0,100
+1,64 %
1-Jahres-Chart
BLACKROCK WORLD MINING TRUST PLC Chart 1 Jahr
5-Tage-Chart
BLACKROCK WORLD MINING TRUST PLC 5-Tage-Chart
PR Newswire
126 Leser
Artikel bewerten:
(0)

BlackRock World Mining Trust Plc - Portfolio Update

BlackRock World Mining Trust Plc - Portfolio Update

PR Newswire

LONDON, United Kingdom, October 17

BLACKROCK WORLD MINING TRUST PLC (LEI - LNFFPBEUZJBOSR6PW155

All information is at 30 September 2024 and unaudited.

Performance at month end with net income reinvested

One

Three

One

Three

Five

Month

Months

Year

Years

Years

Net asset value

6.9%

2.6%

2.4%

25.7%

86.2%

Share price

5.7%

-2.3%

-0.9%

26.6%

108.0%

MSCI ACWI Metals & Mining 30% Buffer 10/40 Index (Net)*

6.9%

2.3%

9.3%

25.4%

72.3%

* (Total return)

Sources: BlackRock, MSCI ACWI Metals & Mining 30% Buffer 10/40 Index, Datastream.

At month end

Net asset value (including income)1:

580.66p

Net asset value (capital only):

571.76p

Share price:

550.00p

Discount to NAV2:

5.3%

Total assets:

£1,236.9m

Net yield3:

6.1%

Net gearing:

11.9%

Ordinary shares in issue:

191,183,036

Ordinary shares held in Treasury:

1,828,806

Ongoing charges4:

0.91%

Ongoing charges5:

0.81%

1 Includes net revenue of 8.90p.

2 Discount to NAV including income.

3 Based on a third interim dividend of 5.50p per share declared on 11 October 2023 with ex-date 23 November 2023 and pay date of 18 December 2023, and a final dividend of 17.00p per share declared on 7 March 2024 with ex date 21 March 2024 and pay date 14 May 2024 in respect of the year ended 31 December 2023, and a first interim dividend of 5.50p per share declared on 10 May 2024 with ex date 30 May 2024 and pay date 24 June 2024, and second interim dividend of 5.50p per share declared on 23 August 2024 with ex date 5 September 2024 and pay date 30 September 2024 in respect of the year ending 31 December 2024.

4 The Company's ongoing charges are calculated as a percentage of average daily net assets and using the management fee and all other operating expenses, excluding finance costs, direct transaction costs, custody transaction charges, VAT recovered, taxation and certain other non-recurring items for the year ended 31 December 2023.

5 The Company's ongoing charges are calculated as a percentage of average daily gross assets and using the management fee and all other operating expenses, excluding finance costs, direct transaction costs, custody transaction charges, VAT recovered, taxation and certain other non-recurring items for the year ended 31 December 2023.

Country Analysis

Total
Assets (%)

Global

62.4

Canada

11.9

Latin America

7.4

Australasia

6.5

United States

5.9

Other Africa

3.9

South Africa

0.7

Indonesia

0.6

Net Current Assets

0.7

-----

100.0

=====

Sector Analysis

Total
Assets (%)

Diversified

36.2

Copper

23.3

Gold

22.1

Steel

4.9

Iron Ore

3.3

Industrial Minerals

3.2

Uranium

2.6

Aluminium

1.3

Platinum Group Metals

1.3

Nickel

1.0

Zinc

0.1

Net Current Assets

0.7

-----

100.0

=====

Ten largest investments

Company

Total Assets %

BHP:

Equity

9.4

Royalty

1.4

Rio Tinto

7.0

Glencore

6.6

Anglo American

5.3

Newmont

5.2

Freeport-McMoRan

4.7

Agnico Eagle Mines

4.5

Vale:

Debenture

2.3

Equity

1.9

Teck Resources

3.7

Wheaton Precious Metals

3.5

5

Asset Analysis

Total Assets (%)

Equity

96.9

Bonds

1.4

Preferred Stock

0.7

Convertible Bond

0.6

Option

-0.3

Net Current Assets

0.7

-----

100.0

=====

Commenting on the markets, Evy Hambro and Olivia Markham, representing the Investment Manager noted:

Performance

The Company's NAV rose by 6.9% in September 2024, performing in line with its reference index, the MSCI ACWI Metals and Mining 30% Buffer 10/40 Index (net return) which increased by 6.9% (performance figures in GBP).

The mining sector performed strongly in September as mined commodity prices rose across the board. For reference, global equity markets, as measured by the MSCI ACWI TR Index, returned +2.3%.

The main news for mining was China announcing a range of stimulus measures. This was welcome news following a ~18-month period in which weak economic data (particularly property-related data) has been the main drag on the sector. The People's Bank of China said it would cut the reserve requirement ratio (the amount of cash banks need to hold in reserve), reduce interest rates for existing mortgages and lower the minimum down payment on home purchases. These monetary measures were then followed by a report that China also plans to issue ~2 trillion yuan of special sovereign bonds as part of a fresh fiscal stimulus package.

In the commodities space, iron ore (62% fe), copper and gold prices rose by 8.4%, 6.3% and 5.1% respectively. Meanwhile, energy costs came down during the month with the Brent oil price falling by 9.8%, suggesting a positive outlook for the miners' margins.

Elsewhere, the uranium price rose by 3.0% as excitement built around nuclear. During the month, Microsoft signed a deal with Constellation Energy to restart its Three Mile Island nuclear plant in Pennsylvania to help power Microsoft's data centres.

Strategy and Outlook

Near term, we expect performance to be driven by the China stimulus situation, which is evolving, and we are watching closely to see if it translates into a pickup in demand. Longer term, we expect mined commodity demand growth to be driven by increased global infrastructure build out, particularly related to the low carbon transition and increased power demand.

Meanwhile, the supply side of the equation is constrained. Mining companies have focused on capital discipline in recent years, meaning they have opted to pay down debt, reduce costs and return capital to shareholders, rather than investing in production growth. This is limiting new supply coming online and there is unlikely to be a quick fix, given the time lags involved in investing in new mining projects. The cost of new projects has also risen significantly and recent mergers and acquisitions activity in the sector suggests that, like us, strategic buyers see an opportunity in existing assets in the listed market, currently trading well below replacement costs. Other issues restricting supply include cases of governments closing mines, permitting issues and a general lack of shovel-ready projects.

Turning to the companies, balance sheets in the sector are very strong relative to history. Despite this, valuations are low relative to historic averages and relative to broader equity markets.

17 October 2024

Latest information is available by typing www.blackrock.com/uk/brwm on the internet. Neither the contents of the Manager's website nor the contents of any website accessible from hyperlinks on the Manager's website (or any other website) is incorporated into, or forms part of, this announcement.




Release

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.